Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)

Coleman K. Obasaju, Lee Bowman, P. Wang, Wei Shen, Katherine B. Winfree, Emily Nash Smyth, Mark E. Boye, William J. John, Thomas Brodowicz, Chandra P. Belani

Annals of Oncology · 2013 · 20 citations · 27 references

DOIFull text

Open access

Concepts

References

27